Xeno Biosciences
Somerville, US · Founded 2015 · Delaware corporation · 3 known investors
Biotech
Founders & leadership
MK
Michael KoerisNamed on SEC filing
HC
Hasan CelikerNamed on SEC filing
DB
David BenoNamed on SEC filing
Investors · 3
Reported raises · per SEC filings
Form D private placements$12.1M disclosed across 4 rounds · 2018–2022
▶$1.5MraisedJan 2023 · 64 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJan 2023 · 64 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David BenoExecutive Officer, Director
- Jeffrey ArnoldDirector
- Michael KoerisDirector
- Tom HughesDirector
- Stan RoseDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.4MraisedAug 2021 · 133 investors · BiotechnologyRule 506(b)
▶$9.4MraisedAug 2021 · 133 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey ArnoldDirector
- Michael KoerisDirector
- Stan RoseDirector
- David BenoExecutive Officer, Director
- Offering amount
- $9.9M
- Amount sold
- $9.4M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$720KraisedFeb 2019 · 21 investors · BiotechnologyRule 506(b)
▶$720KraisedFeb 2019 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael KoerisDirector
- Hasan CelikerExecutive Officer, Director
- David BenoDirector
- Offering amount
- $1.6M
- Amount sold
- $720K
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$450KraisedAug 2018 · 20 investors · BiotechnologyRule 506(b)
▶$450KraisedAug 2018 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael KoerisDirector
- Hasan CelikerExecutive Officer, Director
- David BenoDirector
- Offering amount
- $450K
- Amount sold
- $450K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Xeno Biosciences's investors?
- Xeno Biosciences's investors include Bantam Group, Boston Harbor Angels, Keiretsu Forum.
- How much funding has Xeno Biosciences raised?
- Xeno Biosciences has disclosed $12.1M raised across 4 rounds.
- Where is Xeno Biosciences headquartered?
- Xeno Biosciences is headquartered in Somerville, US.